Aitor Olaso, MSc PharmD

Director, QA/ RA Departm. at Abanza Tecnomed

Aitor Olaso, MSc PharmD has a long and varied work experience. Aitor began their career in 2000 as a Rotational Fellow at Hospital Santa Cruz. From 2003 to 2014, they worked at the Agencia Española de Medicamentos y Productos Sanitarios in various roles, including Scientific Clinical Assessor (Regulatory Affairs Officer), Regulatory Affairs Officer, and Regulatory Associate. In 2014, they moved to the European Medicines Agency as a Scientific Committee Manager. In 2015, they became a Senior Regulatory Consultant - Remote/ Home based as a freelancer. In 2016, they joined Sanofi Pasteur MSD as a Senior Pharmacovigilance Specialist - Vaccines/ LRPV Deputy Spain. In 2017, they took a paternity break, as well as working as a Pharmaceutical Inspector - Public Health at the Gobierno de Navarra. From 2017 to 2018, they were a Senior Manager, Regulatory and Scientific Affairs (RSA) at SPRIM. Most recently, they have been the Director, QA/ RA Departm. at Abanza Tecnomed since 2018.

Aitor Olaso, MSc PharmD, obtained their Post Graduate (MSc) in Infectious diseases from Universidad Autónoma de Madrid in 2012, majoring in Tropical Diseases and Public Health. Prior to that, they obtained their Master of Science (MS) in Regulatory, Authorisation and Development of Medicinal Products in EU from Universitat Autònoma de Barcelona in 2011, majoring in Pharmacy Administration and Pharmacy Policy and Regulatory Affairs. In addition, they have obtained several certifications, including Lead ISO 13485 Auditor from British Standard Institution in 2019, Good Clinical Practices (GPC) from University of Navarra in 2017, Oracle Argus Safety Suite 6 Essentials from Sanofi Pasteur MSD in 2016, Registered pharmacist from General Pharmaceutical Council (GPhC) in 2015, and RAEFAR - Medicines of Human Use from Agencia Española de Medicamentos y Productos Sanitarios in 2014. Aitor also holds a certification in Scilife.

Links

Timeline

  • Director, QA/ RA Departm.

    October 1, 2018 - present